ImmunoGenesis

0 followers


ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.

Industries

Employees

11-50

Links

Org chart

Jim Barlow

Collapse
Annemarie Moseley
Acting Chief Medical Officer
Federica Pericle
Chief Scientific Officer
Michael A. Curran
Founder & SAB Head
Federica O’Brien
Strategic Finance Consultant & CFO
Charles Schweizer
SVP, Clinical Development
Matthew Hemberger
Senior Director, CMC & Quality
Matt H.
Executive Director Of CMC And Quality